Ocker Matthias相关文献与解析，生知库 | 链接生命科学的每一步

Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma

纤维化向恶性肿瘤的转化：肝纤维化和肝细胞癌的生物标志物和治疗契机

期刊:Medical Sciences

影响因子:4.4

doi:10.3390/medsci14010110

Neureiter, Daniel; Kiesslich, Tobias; Ocker, Matthias

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma

社论：胆道癌和肝细胞癌的新型治疗方法

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2023.1320084

Bekric, Dino; Tornesello, Maria Lina; Ocker, Matthias; Mayr, Christian; Kiesslich, Tobias; Neureiter, Daniel

Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End?

FGFR抑制剂试验中的患者选择方法——殊途同归？

期刊:Cells

影响因子:5.2

doi:10.3390/cells11193180

Ellinghaus, Peter; Neureiter, Daniel; Nogai, Hendrik; Stintzing, Sebastian; Ocker, Matthias

发表日期：2022

文献求助收藏

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

肝细胞癌中的铁死亡：机制、药物靶点和临床转化方法

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14071826

Bekric, Dino; Ocker, Matthias; Mayr, Christian; Stintzing, Sebastian; Ritter, Markus; Kiesslich, Tobias; Neureiter, Daniel

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

肝细胞癌的免疫调节治疗策略：从目前的免疫检查点抑制剂到未来的综合治疗

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers13071558

Ocker, Matthias; Mayr, Christian; Kiesslich, Tobias; Stintzing, Sebastian; Neureiter, Daniel

NF-ÎºB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.

NF-κB通路作为治疗COVID-19危重症患者的潜在靶点

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2020.598444

Kircheis Ralf, Haasbach Emanuel, Lueftenegger Daniel, Heyken Willm T, Ocker Matthias, Planz Oliver

Dissecting the immune cell landscape in hepatocellular carcinoma-are we understanding complexity?

剖析肝细胞癌中的免疫细胞图谱——我们是否理解了其复杂性？

期刊:Annals of Translational Medicine

影响因子:

doi:10.21037/atm.2020.03.170

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

肝细胞癌：信号传导、表观遗传和免疫靶点的治疗进展

期刊:World Journal of Gastroenterology

影响因子:5.4

doi:10.3748/wjg.v25.i25.3136

Neureiter, Daniel; Stintzing, Sebastian; Kiesslich, Tobias; Ocker, Matthias

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications

miRNA与肝脏氧化应激的相互作用：从生理学到病理学及临床意义

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms20215266

Klieser, Eckhard; Mayr, Christian; Kiesslich, Tobias; Wissniowski, Till; Fazio, Pietro Di; Neureiter, Daniel; Ocker, Matthias

Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective

胆囊癌辅助治疗的挑战与创新：一项荟萃分析

Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma

纤维化向恶性肿瘤的转化：肝纤维化和肝细胞癌的生物标志物和治疗契机

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma

社论：胆道癌和肝细胞癌的新型治疗方法

Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End?

FGFR抑制剂试验中的患者选择方法——殊途同归？

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

肝细胞癌中的铁死亡：机制、药物靶点和临床转化方法

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

肝细胞癌的免疫调节治疗策略：从目前的免疫检查点抑制剂到未来的综合治疗

NF-ÎºB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.

NF-κB通路作为治疗COVID-19危重症患者的潜在靶点

Dissecting the immune cell landscape in hepatocellular carcinoma-are we understanding complexity?

剖析肝细胞癌中的免疫细胞图谱——我们是否理解了其复杂性？

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

肝细胞癌：信号传导、表观遗传和免疫靶点的治疗进展

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications

miRNA与肝脏氧化应激的相互作用：从生理学到病理学及临床意义